| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |